Home > Boards > Canadian > Biotechs > Bioniche Life Science (TSX:BNC)

1,50 $ TGT by Haywood

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
BioSpecialist Member Profile BioSpecialist  
Wednesday, January 13, 2010 6:42:04 AM
Re: None Post # of 24 
1,50 $ TGT by Haywood
http://www.haywood.com/pdffiles/BNCJul142009.pdf


SECTOR OUTPERFORM; Target: (+$0.20) $1.50; Risk: SPECULATIVE

Partnership Agreement Puts BNC Back on Track

ALPHA: We see significant upside to investors. BNC's share price

reflects a value for the Animal Health division only - that is at 5x

2009 EBITDA or $0.50/shr. We note the US$20M upfront from the Endo

agreement is worth ~$0.25/shr alone. We disagree with the market that

the Human Health division with Urocidin is currently worth zero to BNC

and investors.



Insider activity
http://canadianinsider.com/coReport/allTransactions.php?ticker=bnc


Bioniche Life Science (TSX:BNC) Stock Trading Info:
Bioniche Life Science TSX:BNC Stock Quote Bioniche Life Science TSX:BNC Stock Charts Bioniche Life Science TSX:BNC Financial
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist